The construction of a new model of real estate development is expected to make positive progress. From December 11th to 12th, the Central Economic Work Conference was held in Beijing. The meeting emphasized "stabilizing the property market and stock market". Specific to the key tasks to be done next year, the meeting made it clear that "the real estate market will continue to exert efforts to stop falling and stabilize" and "promote the construction of a new model of real estate development". Experts interviewed generally believe that the Central Economic Work Conference will stabilize the property market and further clarify the policy direction of the real estate sector next year. In 2025, relevant policies to promote the stabilization of the real estate market will continue to exert their strength, and the construction of basic systems related to the new model of real estate development is expected to make positive progress. (Securities Daily)Zhongjin's fixed income: the financing demand is weak under the background of debt conversion, and the monetary policy needs to continue to increase. Zhongjin's fixed income commented on the financial data in November, saying that it is expected that the currency will be loose or significantly accelerated next year, while the short-term interest rate may have a large downside. Under the background of slow real estate recovery, the domestic economy has stabilized relatively moderately, and the long-term interest rate has been affected or relatively limited. Next year, monetary and fiscal cooperation will be closer, and the supply factor of government bonds may not have much disturbance to the long end. Recently, the market has fully priced loose expectations, and the long-term interest rate has dropped rapidly. Next year, with the RRR cut, the short-term interest rate will fall or accelerate, and the yield curve will move down sharply.
In the first 11 months, nearly 90% of stock strategy private equity products realized floating profit. According to the latest statistics released by private placement network, in the first 11 months of this year, the average yield of stock strategy products of private equity institutions with only performance display in 2014 was 18.65%, of which 1753 products realized floating profit, accounting for 87.04%. Specifically, among the sub-strategy products of stock strategy products, subjective multi-strategy products lead the way. The data shows that in the first 11 months of this year, the average yield of 1342 subjective multi-strategy products with performance display was 20.25%, of which 1137 products realized floating profit, accounting for 84.72%. Although the performance of quantitative long strategy products is not as good as that of subjective long strategy products, the gap is not obvious. The data shows that in the first 11 months of this year, the average yield of 460 quantitative long strategy products with performance display was 18.18%, of which 444 products realized floating profit, accounting for 96.52%. (Securities Daily)Fat Donglai: Measures will be taken to control purchasing behavior. Fat Donglai released the control measures on purchasing behavior, saying that from December 14, Fat Donglai will implement the following series of measures to control, including improving the real-name information of membership cards, implementing dynamic code checkout for membership cards, restricting the purchase of goods, limiting the flow of stores, and quickly processing purchasing mechanisms.
Moody's: It is expected that France's public finances will be greatly weakened in the next few years.Challenging the monopoly of Europe and America, Chinese and Indian manufacturers have laid out the track of diet pills. For some time, GLP-1 (glucagon-like peptide -1) diet pills have caught fire in the United States and other western countries, and gradually marched into emerging markets. At present, two major pharmaceutical companies, Novo Nordisk in Denmark and Lilly in the United States, occupy most of the market share in the field of GLP-1 diet pills, but other pharmaceutical companies are also actively deploying the track. In 2026, Novo Nordisk's patent on smeagoutide will expire in China and India, while the patent on liraglutide, the main effective ingredient of the previous generation of GLP-1 diet pills, has expired in China and India. The industry believes that China and India, as two emerging markets, have a strong momentum of innovation and development in the pharmaceutical industry of both countries, and have great potential in the GLP-1 diet pills track. The entry of Chinese and Indian pharmaceutical companies will make the international competition in the field of GLP-1 diet pills more intense. (Global Times)Jiang Xiaojuan argued with European experts that your subsidy for electric vehicles is higher than that of China. Jiang Xiaojuan, a professor at the University of Chinese Academy of Social Sciences, said at the annual financial conference in 2025 that his three visits to Europe last year were all about tariff disputes on electric vehicles. "I calculate the figures particularly carefully. In 2009, the subsidies were fully launched. At that time, we didn't have an electric vehicle to export. The subsidies were not for export, but for electric vehicles and fuel vehicles to compete in the domestic market. In 2016, our exports began to increase, but subsidies also declined rapidly. Therefore, it cannot be said that the competitiveness of electric vehicles in China comes from subsidies, "she said. Even Jiang Xiaojuan calculated the European subsidy data, saying, "Buying a Tesla costs 7,000 to 9,000 euros, which is higher than our subsidy". "My reason is particularly good. I said that we are not exporting. We are competing with domestic fuel vehicles. Your subsidies are more. Why do you say me?" Jiang Xiaojuan said, "Those scholars can't help it, because these are solid data. In the end, they said that regardless of the willy-nilly, our domestic industry was hit too hard and politically unacceptable.". (Rui Jian)
Strategy guide
Strategy guide 12-14
Strategy guide 12-14
Strategy guide